4processed
Form 4 — Insider Transaction
Adaptive Biotechnologies Corp(ADPT)
Filing Date
June 26, 2026
Accepted
June 26, 2026
Accession No.
0001780854-26-000008
CIK
0001478320
Insider Transactions
| Insider | Title | Type | Shares | Price | Value | Owned After | Security | Date |
|---|---|---|---|---|---|---|---|---|
| BENZENO SHARON | Chief Commercial Ofc Imm Med | Other | 11.0K | $12.14 | — | 283.8K | Common Stock | Jun 26, 2026 |
| BENZENO SHARON | Chief Commercial Ofc Imm Med | Other | 11.0K | $21 | — | 272.8K | Common Stock | Jun 26, 2026 |
| BENZENO SHARON | Chief Commercial Ofc Imm Med | Other | 1.8K | $12.14 | — | 274.6K | Common Stock | Jun 29, 2026 |
| BENZENO SHARON | Chief Commercial Ofc Imm Med | Other | 24.9K | $8.46 | — | 299.5K | Common Stock | Jun 29, 2026 |
| BENZENO SHARON | Chief Commercial Ofc Imm Med | Other | 24.9K | $3.99 | — | 324.5K | Common Stock | Jun 29, 2026 |
| BENZENO SHARON | Chief Commercial Ofc Imm Med | Other | 51.6K | $8.12 | — | 376.0K | Common Stock | Jun 29, 2026 |
| BENZENO SHARON | Chief Commercial Ofc Imm Med | Other | 154.8K | $21.14 | — | 221.3K | Common Stock | Jun 29, 2026 |
| BENZENO SHARON | Chief Commercial Ofc Imm Med | Other | 11.0K | $0 | — | 1.8K | Stock Option (right to buy) | Jun 26, 2026 |
| BENZENO SHARON | Chief Commercial Ofc Imm Med | Other | 1.8K | $0 | — | 0 | Stock Option (right to buy) | Jun 29, 2026 |
| BENZENO SHARON | Chief Commercial Ofc Imm Med | Other | 24.9K | $0 | — | 37.4K | Stock Option (right to buy) | Jun 29, 2026 |
| BENZENO SHARON | Chief Commercial Ofc Imm Med | Other | 24.9K | $0 | — | 87.3K | Stock Option (right to buy) | Jun 29, 2026 |
| BENZENO SHARON | Chief Commercial Ofc Imm Med | Other | 51.6K | $0 | — | 113.5K | Stock Option (right to buy) | Jun 29, 2026 |